FLT3 and acute myeloid leukemia: Another possible way to increase the expression of the FLT3 antigen in AML is the use of a tyrosine kinase inhibitor, e.g., crenolanib, which blocks the activity of FLT3, resulting in the upregulation of FLT3 on leukemic cells [119].